علاج الخط الأول لداء الخلايا البدينة الجهازي

References

DOI: 10.1002/ajh.26962

• Treatment options in SM range from observation alone (supplemented by preventative measures to avoid precipitating MC degranulation), to symptom management (e.g., treating pruritus or diarrhea) (Table 6), to supportive measures (e.g., red blood cell transfusion or osteoporosis treatment), to cytoreductive therapy for MC debulking in the setting of aggressive, advanced, or treatment-refractory disease.
• Avoidance of symptom trigger(s) applies to all patients.
• Those at risk of anaphylaxis should carry an emergency kit with self-injected epinephrine (EpiPen) (see text).